Trading Halt: Halted at 7:01:19 p.m. ET - Trading Halt: Halt News Pending
Portfolio Pulse from Benzinga Newsdesk
Trading for Adaptimmune Therapeutics (ADAP) was halted at 7:01:19 p.m. ET pending news. Investors should stay tuned for further updates.
August 01, 2024 | 11:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Trading for Adaptimmune Therapeutics (ADAP) was halted at 7:01:19 p.m. ET pending news. This could indicate significant upcoming news that may impact the stock price.
Trading halts are typically implemented when significant news is pending. This could lead to a substantial price movement once trading resumes, but the direction is uncertain until the news is released.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100